Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $500.00 Price …

Dec 23, 2024 · Read Our Latest Report on Vertex Pharmaceuticals. Vertex Pharmaceuticals Stock Up 2.0 %. VRTX stock traded up $8.00 during trading on Monday, hitting $405.27. 2,204,274 shares of the stock traded hands, compared to its average volume of 1,242,712. …

$500.00
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $500.00 Price …

4 weeks from now

marketbeat.com

$397.27
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut To …

4 weeks from now

Dec 21, 2024 · Shares of Vertex Pharmaceuticals stock opened at $397.27 on Thursday. The company has a quick ratio of 2.20, a current ratio of 2.47 and a debt-to-equity ratio of 0.01. …

etfdailynews.com

$480.00
OFF

Barclays Cuts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target …

4 weeks from now

Dec 23, 2024 · Finally, Scotiabank upped their price target on shares of Vertex Pharmaceuticals from $480.00 to $486.00 and gave the company a “sector perform” rating in a report on …

etfdailynews.com

$460
OFF

Vertex Pharmaceuticals Price Target Lowered To $460 From $550 At …

4 weeks from now

Dec 23, 2024 · Truist analyst Joon Lee lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $460 from $550 and keeps a Buy rating on the shares. The firm moderates its view …

yahoo.com

$600.00
OFF

Barclays Has Lowered Expectations For Vertex Pharmaceuticals …

4 weeks from now

Dec 20, 2024 · HC Wainwright decreased their price objective on Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating on the stock in a research report on Friday. Morgan …

marketbeat.com

$500
OFF

Vertex Pharmaceuticals Price Target Lowered To $500 From $503 At ...

4 weeks from now

Dec 23, 2024 · JPMorgan lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $500 from $503 and keeps an Overweight rating on the shares. Alyftrek’s approval with a …

nasdaq.com

$522
OFF

Vertex Pharmaceuticals Price Target Lowered To $522 From $545

4 weeks from now

Dec 19, 2024 · BofA lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $522 from $545 and keeps a Buy rating on the shares after the company reported topline Phase 2 …

nasdaq.com

$520
OFF

Vertex Pharmaceuticals Price Target Lowered To $520 From $566

4 weeks from now

Dec 20, 2024 · BMO Capital lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $520 from $566 but keeps an Outperform rating on the shares. The company’s Suzetrigine …

nasdaq.com

$550.00
OFF

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut To …

4 weeks from now

Dec 24, 2024 · Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target trimmed by Truist Financial from $550.00 to $460.00 in a research report sent to investors on …

defenseworld.net

$504.50
OFF

What Is The Current Price Target And Forecast For Vertex ...

4 weeks from now

6 days ago · Based on short-term price targets offered by 28 analysts, the average price target for Vertex Pharmaceuticals comes to $504.50. The forecasts range from a low of $325.00 to a …

zacks.com

$494.04
OFF

VRTX Stock Price Target | Vertex Pharmaceuticals Analyst Ratings

4 weeks from now

This price target is based on 31 analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $494.04, with a high forecast …

pricetargets.com

13%
OFF

Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You …

4 weeks from now

6 days ago · NASDAQ: VRTX Vertex Pharmaceuticals. Market Cap. $105B. ... as of December 27, 2024, 4:00 p.m. ET. Vertex Pharmaceuticals (VRTX ... that suzetrigine is more effective for …

fool.com

$418
OFF

Vertex Pharmaceuticals Price Target Lowered To $418 From $509 At ...

4 weeks from now

Dec 20, 2024 · Barclays lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $418 from $509 and keeps an Equal Weight rating on the shares. The firm says the Phase 2 …

nasdaq.com

46%
OFF

Should You Buy Vertex Pharmaceuticals On The Dip Before …

4 weeks from now

Dec 22, 2024 · Vertex Pharmaceuticals (VRTX-0.46%) was on track to become one of this year's biotech winners, with the shares climbing 27% from January through a peak in November. The …

fool.com

$545.00
OFF

SK Wealth Management LLC Takes Position In Vertex …

4 weeks from now

1 day ago · Bank of America cut their price objective on shares of Vertex Pharmaceuticals from $545.00 to $522.00 and set a "buy" rating for the company in a research note on Thursday, …

marketbeat.com

$4.05
OFF

Vertex Stock Crashes On Pain Drug News; Is It Time To Sell Vertex ...

4 weeks from now

Dec 20, 2024 · For the December-ending quarter, analysts polled by FactSet expect Vertex Pharmaceuticals to report adjusted earnings of $4.05 per share on $2.79 billion in sales. …

investors.com

$560
OFF

Vertex Pharmaceuticals Price Target Raised To $560 From $502 At ...

4 weeks from now

Nov 5, 2024 · Bernstein raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $560 from $502 and keeps a Market Perform rating on the shares. The firm notes Vertex delivered …

nasdaq.com

$494.04
OFF

Vertex Pharmaceuticals (VRTX) Stock Forecast & Price Target

4 weeks from now

According to the 31 analysts' twelve-month price targets for Vertex Pharmaceuticals, the average price target is $494.04. The highest price target for VRTX is $586.00, while the lowest price …

marketbeat.com

$451
OFF

Vertex Pharmaceuticals Price Target Raised To $451 From $437

4 weeks from now

Nov 5, 2024 · RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $451 from $437 but keeps a Sector Perform rating on the shares after its Q3 earnings beat. …

nasdaq.com

$600.00
OFF

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives …

4 weeks from now

9 hours ago · Finally, HC Wainwright cut their target price on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a “buy” rating on the stock in a report on Friday, December …

defenseworld.net

$550.00
OFF

Zacks Research Has Positive Estimate For VRTX Q3 Earnings

4 weeks from now

5 days ago · Truist Financial cut their target price on Vertex Pharmaceuticals from $550.00 to $460.00 and set a "buy" rating on the stock in a research note on Monday. Stifel Nicolaus …

marketbeat.com

14%
OFF

Vertex Pharmaceuticals Price Target Raised To $494 From $490

4 weeks from now

Dec 16, 2024 · Stifel raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $494 from $490 and keeps a Hold rating on the shares. With shares up 14% year-to-date, the stock …

nasdaq.com

FAQs about Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $500.00 Price … Coupon?

Is Vertex Pharmaceuticals (VRTX) a good stock to buy?

Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Barclays from $509.00 to $418.00 in a research note published on Friday, Benzinga reports. The firm currently has an equal weight rating on the pharmaceutical company’s stock. Several other analysts also recently commented on VRTX. ...

What is the stock price of Vertex Pharmaceuticals Inc?

The Vertex Pharmaceuticals Inc stock price today is 468.13. What Is the Stock Symbol for Vertex Pharmaceuticals Inc? The stock ticker symbol for Vertex Pharmaceuticals Inc is VRTX. Is VRTX the Same as $VRTX? $VRTX is a common way to refer to the Vertex Pharmaceuticals Inc ticker symbol in social media, forums, and online discussions. ...

Is Vertex Pharmaceuticals Incorporated a risky investment?

Vertex Pharmaceuticals Incorporated has a PE ratio of -233.23, which suggests that the company is currently not generating profits relative to its stock price, making it a riskier investment. Despite recent revenue growth, the company is projected to post an EPS of -1.83 for the current fiscal year, which may signal ongoing financial difficulties. ...

Is Vertex Pharmaceuticals a good buy?

Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Vertex Pharmaceuticals has received a consensus rating of Moderate Buy. The company's average rating score is 2.52, and is based on 17 buy ratings, 10 hold ratings, and 3 sell ratings. ...

What happened to vertex stock?

Vertex stock has lagged the market since then, with a major blow coming last week after the company reported lackluster data from a phase II study for its non-opioid drug. ...

How do I receive news & ratings for Vertex Pharmaceuticals?

Receive News & Ratings for Vertex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter. ...